Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2015, Article ID 848921, 6 pages
http://dx.doi.org/10.1155/2015/848921
Research Article

Hyperglycaemic Environment: Contribution to the Anaemia Associated with Diabetes Mellitus in Rats Experimentally Induced with Alloxan

Department of Biomedical Sciences, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomosho 210214, Oyo State, Nigeria

Received 16 September 2015; Revised 10 November 2015; Accepted 12 November 2015

Academic Editor: Aurelio Maggio

Copyright © 2015 Oseni Bashiru Shola and Fakoya Olatunde Olugbenga. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Guyton and J. E. Hall, A TextBook of Medical Physiology, W.B. Saunders Company, Philadelphia, Pa, USA, 12th edition, 2012.
  2. O. J. Ochei and A. A. Kolhatkar, Medical Laboratory Science Theory and Practice, Tata McGraw-Hill, New Delhi, India, 1st edition, 2001.
  3. R. K. Murray, D. K. Granner, P. A. Mayes, and V. W. Rodwell, Harper's Iluustrated Biochemistry, McGraw-Hill, New Delhi, India, 26th edition, 2003.
  4. S. K. Jain, “Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells,” The Journal of Biological Chemistry, vol. 264, no. 35, pp. 21340–21345, 1989. View at Google Scholar · View at Scopus
  5. C. D. Brown, H. S. Ghali, Z. Zhao, L. L. Thomas, and E. A. Friedman, “Association of reduced red blood cell deformability and diabetic nephropathy,” Kidney International, vol. 67, no. 1, pp. 295–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Agrawal, R. Bhatnagar, T. Smart et al., “Assessment of red blood cell deformability by optical tweezers in diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 56, no. 7, p. 5183, 2015. View at Google Scholar
  7. T. Rimmer, J. Fleming, and E. M. Kohner, “Hypoxic viscosity and diabetic retinopathy,” British Journal of Ophthalmology, vol. 74, no. 7, pp. 400–404, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. I. Cho, M. P. Mooney, and D. J. Cho, “Hemorheological disorders in diabetes mellitus,” Journal of Diabetes Science and Technology, vol. 2, no. 6, pp. 1130–1138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shin, Y. Ku, M.-S. Park, J.-H. Jang, and J.-S. Suh, “Rapid cell-deformability sensing system based on slit-flow laser diffractometry with decreasing pressure differential,” Biosensors and Bioelectronics, vol. 20, no. 7, pp. 1291–1297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Chien, “Red cell deformability and its relevance to blood flow,” Annual Review of Physiology, vol. 49, pp. 177–192, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Hasslacher, “Anaemia in patients with diabetic nephropathy—prevalence, causes and clinical consequences,” European Cardiology Review, vol. 3, no. 1, pp. 80–82, 2007. View at Publisher · View at Google Scholar
  12. Committee for the Update of the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals, Committee for the Update of the Care and Use of Laboratory Animals, Washington, DC, USA, 2001, http://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals.pdf.
  13. D. C. Ashok, N. P. Shrimant, M. G. Pradeep, and U. A. Akalpita, “Optimization of Alloxan dose is essential to induce stable diabetes for prolonged period,” Asian Journal of Biochemistry, vol. 2, no. 6, pp. 402–408, 2007. View at Publisher · View at Google Scholar
  14. J. Babara and B. Imelda, “Basic haematological techniques,” in Practical Hematology, S. M. Lewis, B. J. Bain, and I. Bates, Eds., pp. 139–140, Edinburgh ChurchHill LivingStone, Edinburgh, UK, 2004. View at Google Scholar
  15. R. Ankur and A. Shahjad, “Alloxan induced diabetes: mechanisms and effects,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, pp. 819–823, 2012. View at Google Scholar
  16. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  17. M. Misra and U. Aiman, “Alloxan: an unpredictable drug for diabetes induction,” Indian Journal of Pharmacology, vol. 44, no. 4, pp. 538–539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. K. Jain and R. K. Arya, “Anomalies in alloxan-induced diabetic model: it is better to standardize it first,” Indian Journal of Pharmacology, vol. 43, article 91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. I. J. Pincus, J. J. Hurwitz, and M. E. Scott, “Effect of rate of injection of alloxan on development of diabetes in,” Proceedings of the Society for Experimental Biology and Medicine., vol. 86, no. 3, pp. 553–554, 1954. View at Publisher · View at Google Scholar · View at Scopus
  20. C. C. Rerup, “Drugs producing diabetes through damage of the insulin secreting cells,” Pharmacological Reviews, vol. 22, no. 4, pp. 485–518, 1970. View at Google Scholar · View at Scopus
  21. A. W. Harman and L. J. Fischer, “Alloxan toxicity in isolated rat hepatocytes and protection by sugars,” Biochemical Pharmacology, vol. 31, no. 23, pp. 3731–3736, 1982. View at Publisher · View at Google Scholar · View at Scopus
  22. K. B. Pandey and S. I. Rizvi, “Biomarkers of oxidative stress in red blood cells,” Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic, vol. 155, no. 2, pp. 131–136, 2011. View at Publisher · View at Google Scholar
  23. J. Carroll, M. Raththagala, W. Subasinghe et al., “An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP,” Molecular BioSystems, vol. 2, no. 6, pp. 305–311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Mohandas and P. G. Gallagher, “Red cell membrane: past, present, and future,” Blood, vol. 112, no. 10, pp. 3939–3948, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Evans, N. Mohandas, and A. Leung, “Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration,” The Journal of Clinical Investigation, vol. 73, no. 2, pp. 477–488, 1984. View at Publisher · View at Google Scholar · View at Scopus
  26. G. S. Redding, D. M. Record, and B. U. Raess, “Calcium-stressed erythrocyte membrane structure and function for assessing glipizide effects on transglutaminase activation,” Proceedings of the Society for Experimental Biology and Medicine, vol. 196, no. 1, pp. 76–82, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. J. P. Fruehauf and F. L. Meyskens Jr., “Reactive oxygen species: a breath of life or death?” Clinical Cancer Research, vol. 13, no. 3, pp. 789–794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. McMullin, “The molecular basis of disorders of red cell enzymes,” Journal of Clinical Pathology, vol. 52, no. 4, pp. 241–244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Maurizio, A. Luciano, and M. Walter, “The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases,” Cardiores, vol. 75, no. 1, pp. 21–28, 2007. View at Google Scholar
  30. S. Tiwari and J. F. Ndisang, “The heme oxygenase system and type-1 diabetes,” Current Pharmaceutical Design, vol. 20, no. 9, pp. 1328–1337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Xia, T. Inoguchi, T. S. Kern, R. L. Engerman, P. J. Oates, and G. L. King, “Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia,” Diabetes, vol. 43, no. 9, pp. 1122–1129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. E. P. Feener, P. Xia, T. Inoguchi, T. Shiba, M. Kunisaki, and G. L. King, “Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression,” Contributions to Nephrology, vol. 118, pp. 180–187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Y. W. Lee and S. S. M. Chung, “Contributions of polyol pathway to oxidative stress in diabetic cataract,” The FASEB Journal, vol. 13, no. 1, pp. 23–30, 1999. View at Google Scholar · View at Scopus
  34. A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager, “Advanced glycation end products: sparking the development of diabetic vascular injury,” Circulation, vol. 114, no. 6, pp. 597–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. G. Mohanty, E. Nagababu, and J. M. Rifkind, “Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging,” Frontiers in Physiology, vol. 5, article 84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Bryszewska, I. B. Zavodnik, A. Niekurzak, and K. Szosland, “Oxidative processes in red blood cells from normal and diabetic individuals,” Biochemistry and Molecular Biology International, vol. 37, no. 2, pp. 345–354, 1995. View at Google Scholar · View at Scopus
  38. B. Halliwell and J. M. C. Gutteridge, “Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death,” in Free Radicals in Biology and Medicine, pp. 187–267, Oxford University Press, New York, NY, USA, 4th edition, 2007. View at Google Scholar
  39. I. Maridonneau, P. Barquet, and R. P. Garay, “Na+ /K+ transport damage induced by oxygen free radicals in human red cell membranes,” The Journal of Biological Chemistry, vol. 258, pp. 3107–3117, 1983. View at Google Scholar
  40. K. B. Pandey and S. I. Rizvi, “Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult,” Phytotherapy Research, vol. 24, no. 1, pp. S11–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. B. Pandey and S. I. Rizvi, “Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 6, pp. 1093–1097, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Goodarzi, A. A. Moosavi-Movahedi, M. Habibi-Rezaei et al., “Hemoglobin fructation promotes heme degradation through the generation of endogenous reactive oxygen species,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 130, pp. 561–567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Samaja, A. Rubinacci, R. Motterlini, A. De Ponti, and N. Portinaro, “Red cell aging and active calcium transport,” Experimental Gerontology, vol. 25, no. 3-4, pp. 279–286, 1990. View at Publisher · View at Google Scholar · View at Scopus
  44. C. R. Kiefer and L. M. Snyder, “Oxidation and erythrocyte senescence,” Current Opinion in Hematology, vol. 7, no. 2, pp. 113–116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. P. A. Ney, M. M. Christopher, and R. P. Hebbel, “Synergistic effects of oxidation and deformation on erythrocyte monovalent cation leak,” Blood, vol. 75, no. 5, pp. 1192–1198, 1990. View at Google Scholar · View at Scopus
  46. A. V. Hoffbrand, S. M. Lewis, and E. G. D. Tuddenham, Postgraduate Haematology, Arnold Medical Books, London, UK, 4th edition, 2001.
  47. N. Bersch, J. E. Groopman, and D. W. Golde, “Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 55, no. 6, pp. 1209–1211, 1982. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Ritz and V. Haxsen, “Diabetic nephropathy and anaemia,” European Journal of Clinical Investigation, Supplement, vol. 35, no. 3, pp. 66–74, 2005. View at Publisher · View at Google Scholar · View at Scopus